Podcasts about Purdue Pharma

Send us a textGood morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the intricate tapestry of scientific advancements, regulatory decisions, and strategic maneuvers shaping our industry.One of the notable stories involves Agios Pharmaceuticals, which is pushing forward with its sickle cell disease treatment, Pyrukynd, for FDA approval. This comes despite mixed results from their Phase 3 clinical trials, which led to a significant drop in their stock value. This scenario underscores the complexities of navigating clinical trial outcomes while pursuing breakthroughs in treating challenging diseases like sickle cell.Arrowhead Pharmaceuticals has marked a significant milestone with the FDA's approval of Plozasiran. This achievement not only marks Arrowhead's entry into the commercial sector but also highlights the competitive dynamics within biotech, as companies like Ionis Pharmaceuticals vie for market dominance with innovative therapies. Further strengthening its position, Arrowhead also received FDA approval for Redemplo, a siRNA-based therapeutic for rare genetic metabolic disorders. Despite facing volatility due to safety concerns in its partnership with Sarepta Therapeutics, this approval underscores RNA interference therapies' potential in precision medicine.In corporate strategy news, Alkermes is making moves to acquire Avadel Pharmaceuticals, offering up to $2.37 billion and overshadowing a competing bid from Lundbeck. Such acquisitions are part of a broader trend of consolidation in the industry aimed at expanding portfolios and market reach. Avadel's decision to accept Alkermes' revised offer over Lundbeck's bid highlights ongoing consolidation trends as companies expand their portfolios in competitive markets like narcolepsy drugs.On the investment front, Celltrion has committed $478 million to upgrade a U.S. manufacturing facility acquired from Eli Lilly. This expansion is crucial for increasing manufacturing capabilities within the biosimilars sector, where demand for cost-effective therapeutics is on the rise. Additionally, Celltrion's exploration beyond biosimilars with a potential $350 million deal involving Trioar's antibody platform demonstrates ambition to diversify its portfolio towards innovative biologics.Teva Pharmaceuticals is fostering innovation by inviting startups to tackle key challenges within biopharma through a global platform. This initiative reflects a growing trend toward open innovation and collaboration, seeking novel solutions to complex issues across research and development and manufacturing efficiencies.In regulatory news, the controversial $7.4 billion settlement plan involving the Sackler family and Purdue Pharma has received approval from a bankruptcy judge. This paves the way for Purdue's transformation into Knoa Pharma and highlights ongoing legal and ethical reckonings related to opioid liabilities within the industry.Cytokinetics remains committed to its independent path as it awaits FDA approval for its cardiovascular drug Aficamtem. The company's determination to commercialize without big pharma support reflects a trend where smaller biotech firms strive for autonomy while bringing first-in-class drugs to market.On an infectious disease front, Merck has demonstrated significant progress with its HIV treatment Islatravir in Phase 3 trials. This places Islatravir as a potential competitor against Gilead's Biktarvy, showcasing ongoing innovation within antiviral drug development.Additionally, Dexcom has gained clearance for its type 2 diabetes software integrating continuous glucose monitoring technology. This advancement exemplifies how digital health technologies are transforming chronic disease management bySupport the show

Today's Headlines: The House finally voted on releasing the Epstein files, and it was a blowout: 427–1, with Louisiana Republican Clay Higgins as the lone no vote. Speaker Mike Johnson is still trying to get the Senate to redact names (interesting), but survivors held a powerful press conference beforehand urging Trump to stop playing politics and just release the files himself. Meanwhile, the first real accountability domino fell: Larry Summers is stepping back from Harvard and the Center for American Progress over his deep Epstein ties — though OpenAI's board is staying suspiciously quiet about whether he's out there too. Over in the Oval Office, Trump hosted Saudi crown prince Mohammed bin Salman for what was supposed to be a big investment-and-F-35s photo op, but it immediately derailed when reporters asked about Epstein and, awkwardly, MBS's role in the murder of Jamal Khashoggi. Trump waved that off with a casual “things happen,” then snapped at ABC's Mary Bruce for asking why he hasn't released the Epstein files, calling her a “terrible reporter” and demanding ABC lose its broadcast license. Very normal, very innocent behavior. In foreign policy news, the UK has reportedly stopped sharing intel on drug smuggling boats over concerns about recent U.S. strikes — something Secretary of State Marco Rubio swears is absolutely not happening because “it didn't come up once.” The courts were also busy. A federal judge said the DOJ's case against James Comey may have been tainted by “profound investigative missteps,” another court blocked Texas's new gerrymandered congressional map for 2026 (pending the inevitable SCOTUS appeal), and a bankruptcy judge finally approved a $7 billion Purdue Pharma settlement after six years of legal trench warfare — money that will go to families, governments, hospitals, and tribes devastated by the opioid crisis. Resources/Articles mentioned in this episode: CNN: Live updates: Trump presidency, Epstein files release heads to House for vote AP News: Former Treasury Secretary Larry Summers steps down from public commitments after Epstein emails ABC News: Trump defends Saudi crown prince over Khashoggi killing, threatens ABC News in White House meeting – as it happened | Mohammed bin Salman People: Donald Trump Lashes Out at ABC Reporter over Another Epstein Question, Saying 'Your Crappy Company' Should Lose Its FCC License NBC News: U.K. withholds intelligence on alleged drug boats over U.S. strikes, sources say CNN: Judge says James Comey indictment may be tainted by ‘profound investigative missteps' Democracy Docket: Federal Court Blocks Texas Gerrymander - Democracy Docket Financial Times: Judge rules Purdue Pharma must pay $7bn in bankruptcy settlement Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

On today's Gist Healthcare Podcast: Medicare Part B premiums rise 10 percent next year, the White House is in talks about extending ACA enhanced tax credits, and a federal judge signs off on Purdue Pharma's bankruptcy plan tied to the opioid crisis. Hosted on Acast. See acast.com/privacy for more information.

In this episode of the Medical Sales Podcast, Samuel sits down with Jennifer Jones, a former top Purdue Pharma rep who lived through the rise, collapse, and aftermath of one of the most controversial chapters in pharmaceutical history. Jennifer opens up about her early passion for pain management, what reps were taught, how Q12 vs Q8 dosing shaped patient experiences, and the moment Purdue shut down while she was on vacation. She shares the emotional toll of grand jury testimony, FBI investigations, and watching once-trusted leaders face prison time, while also revealing the patients and physicians who were genuinely trying to do the right thing. From navigating "pill mill" stereotypes to seeing pain doctors wrongly targeted, Jennifer gives a raw, inside look at the complexities reps faced long before the media headlines. Now a thriving medical device rep in cardiology, she talks about rebuilding her career, stepping into entrepreneurship, and rediscovering her purpose in healthcare. This is one of the most honest conversations ever recorded about pharma, pain management, and what it means to survive, grow, and lead in medical sales.   Connect with Jennifer Jones: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How »

Connecticut will get $64 million from Purdue Pharma. Regulators reject a bid from Eversource to sell Aquarion. Structural issues persist on a bridge to Fire Island. Plus, the latest from WSHU's new series Good at Heart.

Mike Quinn, Plaintiff Attorney, joins Lisa Dent to discuss a judge approving OxyContin-maker Purdue Pharma's latest deal to settle thousands of lawsuits related to OxyContin use. Quinn shares his experience representing people and families who were affected by OxyContin abuse.

On today's episode: DHS plans to deploy 250 border agents to Louisiana in major immigration sweep, AP sources say. Congress acts swiftly to force release of Epstein files, and Trump agrees to sign bill. Poland to shut Russia's last consulate in the country after railway sabotage. Sharp disagreements over economy threaten Federal Reserve interest rate cut. Fear spreads as federal immigration crackdown in North Carolina expands to Raleigh. Federal judges block Texas from using its new US House map in the 2026 midterms. After years away from Washington, Saudi crown prince gets warm embrace from Trump, US business. Tennessee judge blocks Trump's use of National Guard in Memphis but gives time for government appeal. Judge approves opioid settlement for Purdue Pharma and Sackler family members who own the company. Texas governor declares Muslim civil rights group a terrorist organization. Stocks drop after another jarring day as worries about too-high prices keep dogging Nvidia, bitcoin. After years away from Washington, Saudi crown prince gets warm embrace from Trump, US business. The Pistons win again to improve to 13-2, a record-setting season debut for the NBA’s all-time leading scorer, the top three stay the same in the latest CFP rankings, a four-time NFL MVP quarterback could play through an injury while another QB remains sidelined and a trade in baseball. Cowboys will try to keep winning for Kneeland; mental health in the NFL. Commissioner Jim Phillips says ACC freed to focus on future with legal fight resolved. Russian aerial attacks target multiple Ukraine regions. Israeli airstrike on a Palestinian refugee camp in Lebanon kills 13 people, Lebanese ministry says. 1 Israeli killed and 3 wounded in West Bank attack as UN approves Trump's Gaza plan. —The Associated Press About this program Host Terry Lipshetz is managing editor of the national newsroom for Lee Enterprises. Besides producing the daily Hot off the Wire news podcast, Terry conducts periodic interviews for this Behind the Headlines program, co-hosts the Streamed & Screened movies and television program and is the former producer of Across the Sky, a podcast dedicated to weather and climate. Theme music The News Tonight, used under license from Soundstripe. YouTube clearance: ZR2MOTROGI4XAHRX

AP correspondent Marcela Sanchez reports on a major opioid settlement.

In our news wrap Friday, a federal bankruptcy judge will approve Purdue Pharma’s latest deal to settle lawsuits over the damage of opioids, Charlotte is bracing for an expected surge of federal agents as President Trump looks to expand his immigration crackdown and the Trump administration is dropping plans to make airlines compensate passengers for flight delays caused by carriers. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

– Kryzys opioidowy zabił setki tysięcy Amerykanów. Teraz administracja Trumpa chce odpowiedzieć siłą – relacjonuje korespondent Radia Wnet. U wybrzeży Wenezueli znajduje się amerykański lotniskowiec. Stany Zjednoczone są już w pełnej gotowości do dokonania powietrznych uderzeń na cele lądowe w Wenezueli– mówi korespondent Radia Wnet Tomasz Grzywaczewski. To element nowej amerykańskiej operacji przeciw kartelom narkotykowym.Południowa Włócznia uderzy a kartele?Sekretarz wojny Pete Hegseth ogłosił rozpoczęcie operacji „Południowa Włócznia”, której celem ma być walka z narkoterrorystami w całej Ameryce Łacińskiej. Grzywaczewski podkreśla, że do wybrzeży Wenezueli dotarła już grupa uderzeniowa lotniskowca USS Gerald Ford, a w regionie znajdują się amerykańskie okręty, łódź podwodna i samoloty F-35.Nie ma decyzji o bombardowaniach, ale zgromadzony potencjał wskazuje, że takie uderzenia są bardzo możliwe. Celem może być nie tylko infrastruktura karteli, ale także obalenie reżimu Nicolása Maduro– ocenia korespondent.Narkotykowi terroryściUSA uznały wcześniej kartele za organizacje terrorystyczne, co daje podstawy prawne do operacji wojskowych. Sam Maduro – jak przypomina Grzywaczewski – jest oskarżany o kierowanie „państwowym kartelem narkotykowym”. Stany Zjednoczone wyznaczyły nagrodę 50 mln dolarów za jego ujęcie.Korespondent wskazuje, że działania militarne są reakcją na katastrofalny kryzys opioidowy w USA.Fentanyl i inne opioidy doprowadziły do śmierci setek tysięcy Amerykanów. To kryzys, jakiego ten kraj nie widział– mówi.Kryzys opioidowy i Purdue PharmaPrzypomina też, że początkiem epidemii opioidowej była legalna działalność firmy Purdue Pharma, która masowo wprowadzała na rynek lek OxyContin jako „bezpieczny”, mimo gigantycznego potencjału uzależniającego.To był skandal niewyobrażalnej skali– dodaje.Według Grzywaczewskiego USA mogą w kolejnych dniach rozpocząć działania militarne nie tylko w Wenezueli, ale w całej Ameryce Południowej w ramach południowego dowództwa armii.

This week we talk about OxyContin, opium, and the British East India Company.We also discuss isotonitazene, fentanyl, and Perdue.Recommended Book: The Thinking Machine by Stephen WittTranscriptOpioids have been used as painkillers by humans since at least the Neolithic period; there's evidence that people living in the Iberian and Italian Peninsulas kept opium poppy seeds with them, and there's even more evidence that the Ancient Greeks were big fans of opium, using it to treat pain and as a sleep aid.Opium was the only available opioid for most of human history, and it was almost always considered to be a net-positive, despite its downsides. It was incorporated into a mixture called laudanum, which was a blend of opium and alcohol, in the 17th century, and that helped it spread globally as Europeans spread globally, though it was also in use locally, elsewhere, especially in regions where the opium poppy grew naturally.In India, for instance, opium was grown and often used for its painkilling properties, but when the British East India Company took over, they decided to double-down on the substance as a product they could monopolize and grow into a globe-spanning enterprise.They went to great lengths to expand production and prevent the rise of potential competitors, in India and elsewhere, and they created new markets for opium in China by forcing the product onto Chinese markets, initially via smuggling, and then eventually, after fighting a series of wars focused on whether or not the British should be allowed to sell opium on the Chinese market, the British defeated the Chinese. And among other severely unbalanced new treaties, including the ceding of the Kowloon peninsula to the British as part of Hong Kong, which they controlled as a trading port, and the legalization of Christians coming into the country, proselytizing, and owning property, the Chinese were forced to accept the opium trade. This led to generations of addicts, even more so than before, when opium was available only illicitly, and it became a major bone of contention between the two countries, and informed China's relationship with the world in general, especially other Europeans and the US, moving forward.A little bit later, in the early 1800s, a German pharmacist was able to isolate a substance called morphine from opium. He published a paper on this process in 1817, and in addition to this being the first alkaloid, the first organic compound of this kind to be isolated from a medicinal plant, which was a milestone in the development of modern drug discovery, it also marked the arrival of a new seeming wonder drug, that could ease pain, but also help control cold-related symptoms like coughing and gut issues, like diarrhea. Like many such substances back in the day, it was also often used to treat women who were demonstrating ‘nervous character,' which was code for ‘behaving in ways men didn't like or understand.'Initially, it was thought that, unlike with opium, morphine wasn't addictive. And this thinking was premised on the novel application method often used for morphine, the hypermedia needle, which arrived a half-century after that early 1800s isolation of morphine from opium, but which became a major driver of the new drug's success and utility. Such drugs, derived scientifically rather than just processing a plant, could be administered at specific, controllable doses. So surely, it was thought, this would alleviate those pesky addictive symptoms that many people experienced when using opioids in a more natural, less science-y way.That, of course, turned out not to be the case. But it didn't stop the progression of this drug type, and the further development of more derivations of it, including powerful synthetic opioids, which first hit the scene in the mid-20th century.What I'd like to talk about today is the recent wave of opioid addictions, especially but not exclusively in the US, and the newest concern in this space, which is massively more powerful than anything that's come before.—As I mentioned, there have been surges in opioid use, latent and externally forced, throughout modern human history.The Chinese saw an intense wave of opioid addiction after the British forced opium onto their markets, to the point that there was a commonly held belief that the British were trying to overthrow and enslave the Chinese by weighing them down with so many addicts who were incapable of doing much of anything; which, while not backed by the documentation we have from the era—it seems like they were just chasing profits—is not impossible, given what the Brits were up to around the world at that point in history.That said, there was a huge influx in opioid use in the late-1980s, when a US-based company called Purdue Pharma began producing and pushing a time-released opioid medication, which really hit the big-time in 1995, when they released a version of the drug called OxyContin.OxyContin flooded the market, in part because it promised to help prevent addiction and accidental overdose, and in part because Purdue was just really, really good at marketing it; among other questionable and outright illegal things it did as part of that marketing push, it gave kickbacks to doctors who prescribed it, and some doctors did so, a lot, even when patients didn't need it, or were clearly becoming addicted.By the early 2000s, Purdue, and the Sackler family that owned the company, was spending hundreds of millions of dollars a year to push this drug, and they were making billions a year in sales.Eventually the nature of Purdue's efforts came to light, there were a bunch of trials and other legal hearings, some investigative journalists exposed Purdue's foreknowledge of their drug's flaws, and there was a big government investigation and some major lawsuits that caused the collapse of the company in 2019—though they rebranded in 2021, becoming Knoa Pharma.All of which is interesting because much like the forced legalization of opium on Chinese markets led to their opioid crisis a long time ago, the arrival of this incredibly, artificially popular drug on the US market led to the US's opioid crisis.The current bogeyman in the world of opioids—and I say current because this is a fast-moving space, with new, increasingly powerful or in some cases just a lot cheaper drugs arriving on the scene all the time—is fentanyl, which is a synthetic opioid that's about 30-50 times more potent than heroin, and about 100 times as potent as morphine. It has been traditionally used in the treatment of cancer patients and as a sedative, and because of how powerful it is, a very small amount serves to achieve the desired, painkilling effect.But just like other opioids, its administration can lead to addiction, people who use it can become dependent and need more and more of it to get the same effects, and people who have too much of it can experience adverse effects, including, eventually, death.This drug has been in use since the 1960s, but illicit use of fentanyl began back in the mid-1970s, initially as its own thing, but eventually to be mixed in with other drugs, like heroin, especially low-quality versions of those drugs, because a very small amount of fentanyl can have an incredibly large and potent effect, making those other drugs seem higher quality than they are.That utility is also this drug's major issue, though: it's so potent that a small amount of it can kill, and even people with high opioid tolerances can see those tolerances pushed up and up and up until they eventually take a too-large, killing dose.There have been numerous efforts to control the flow of fentanyl into the US, and beginning in the mid-20-teens, there were high-profile seizures of the illicitly produced stuff around the country. As of mid-2025, China seems to be the primary source of most illicit fentanyl around the world, the drug precursor produced in China, shipped to Mexico where it's finalized and made ready for market, and then smuggled into the US.There have been efforts to shut down this supply chain, including recent tariffs put on Chinese goods, ostensibly, in part at least, to get China to handle those precursor suppliers.Even if that effort eventually bears fruit, though, India seems to have recently become an alternative source of those precursors for Mexican drug cartels, and for several years they've been creating new markets for their output in other countries, like Nigeria, Indonesia, and the Netherlands, as well.Amidst all that, a new synthetic drug, which is 40-times as potent as fentanyl, is starting to arrive in the US, Europe, and Australia, and has already been blamed for thousands of deaths—and it's thought that that number might be a significant undercount, because of how difficult it can be to attribute cause with these sorts of drugs.Nitazenes were originally synthesized back in the 1950s in Austria, and they were never sold as painkillers because they were known, from the get-go, to be too addictive, and to have a bad tradeoff ratio: a little bit of benefit, but a high likelihood of respiratory depression, which is a common cause of death for opioid addicts, or those who accidentally overdose on an opioid.One nitazene, called isotonitazene, first showed up on US drug enforcement agency radars back in 2019, when a shipment was intercepted in the Midwest. Other agencies noted the same across the US and Europe in subsequent years, and this class of drugs has now become widespread in these areas, and in Australia.It's thought that nitazenes might be seeing a surge in popularity with illicit drugmakers because their potency can be amped up so far, way, way higher than even fentanyl, and because their effects are similar in many ways to heroin.They can also use them they way they use fentanyl, a tiny bit blended into lower-quality versions of other drugs, like cocaine, which can save money while also getting their customers, who may not know what they're buying, hooked, faster. For context, a fifth of a grain of nitazene salt can be enough to kill a person, so it doesn't take much, less than that, if they want to keep their customers alive, to achieve the high they're looking for. A little bit goes a long, long way.This class of drugs is also difficult to detect, which might be part of the appeal for drug makers, right now. Tests that detect morphine, heroin, and fentanyl do not detect natazines, and the precursors for this type of drug, and the drugs themselves, are less likely to be closely watched, or even legally controlled at the levels of more popular opioids, which is also likely appealing to groups looking to get around existing clampdown efforts.Right now, drug agencies are in the process of updating their enforcement and detection infrastructure, and word is slowly getting out about nitazenes and the risk they potentially pose. But it took years for sluggish government agencies to start working on the issue of fentanyl, which still hasn't been handled, so it's anyone's guess as to when and if the influx of nitazenes will be addressed on scale.Show Noteshttps://www.wired.com/story/a-new-type-of-opioid-is-killing-people-in-the-us-europe-and-australia/https://link.springer.com/article/10.1007/BF02161116https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(24)00024-0/fulltexthttps://www.theguardian.com/society/2025/nov/03/nitazenes-synthetic-opioid-drug-500-times-stronger-than-heroin-fatalhttps://www.nature.com/articles/d41586-025-03280-5https://theconversation.com/10-times-stronger-than-fentanyl-nitazenes-are-the-latest-deadly-development-in-the-synthetic-opioid-crisis-265882https://www.cato.org/blog/fentanyl-nitazenes-why-drug-war-keeps-making-danger-worsehttps://www.cfr.org/backgrounder/fentanyl-and-us-opioid-epidemichttps://en.wikipedia.org/wiki/Purdue_Pharmahttps://en.wikipedia.org/wiki/Oxycodonehttps://en.wikipedia.org/wiki/Fentanylhttps://en.wikipedia.org/wiki/Nitazeneshttps://en.wikipedia.org/wiki/Opioidhttps://en.wikipedia.org/wiki/Timeline_of_the_opioid_epidemichttps://en.wikipedia.org/wiki/Opioid_epidemic This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe

The candidates for Nassau County Executive square off in a contentious debate. Connecticut could soon have another professional sports team. Creditors approve the latest settlement plan from Purdue Pharma. Plus, the troubling trend for our region's forests.

New York City Rent stabilized apartments are getting a price hike. Starting tomorrow, renters will have a 3% increase on one-year leases and a 4.5% rise on two-year leases. This applies to about 1 million apartments across the city. New York City is looking to secure millions of dollars in a settlement from Purdue Pharma, the makers of Oxycontin, to tackle the ongoing opioid crisis. WFUV's Xenia Gonikberg tells us more about what it means for the city. As New York state opens the door to full-scale casinos in the five boroughs, millionaires, celebrities, and political insiders are staking their bets in what's seen as a high stakes gamble for the city's future. Host/Producer: Lainey Nguyen Editor: Tess Novotny Reporter: Xenia Gonikberg Reporter: Joseph Vizza Theme Music: Joe Bergsieker

Puntata a cura di Jacopo Bulgarini d'Elci e Livio PacellaLa crisi degli oppioidi negli USA, una tragedia che da quasi 30 anni ha causato - e continua a causare - la morte di centinaia di migliaia di americani, ha dato vita di recente a diverse opere tra cinema e serialità televisiva.Dopesick è una miniserie drammatica (Hulu, 2021) in 8 episodi, in Italia visibile su Disney + e Star. Basata sul libro di Beth Macy (Dopesick: Dealers, Doctors and the Drug Company that Addicted America) del 2018, è uno dei ritratti più duri che vi siano in circolazione sulla catastrofe legata alla diffusione dell'OxyContin, ad opera della Purdue Pharma, di proprietà della famiglia Sackler. Con un grande Michael Keaton (premio Emmy) a guidare un ottimo cast. “2 voci, 1 serie”: dialoghi sulle cose che ci piacciono, o ci interessano, nel podcast di Mondoserie.Leggi anche il nostro articolo su Dopesick: https://www.mondoserie.it/dopesick/ MUSICA NELLA PUNTATA:I Am a Man Who Will Fight for Your Honor di Chris Zabriskie è un brano concesso in uso tramite licenza Creative Commons Attribution 4.0. https://creativecommons.org/licenses/by/4.0/ Fonte: http://chriszabriskie.com/honor/ Artista: http://chriszabriskie.com/ Parte del progetto: https://www.mondoserie.it/  Iscriviti al podcast sulla tua piattaforma preferita o su: https://www.spreaker.com/show/mondoserie-podcast  Collegati a MONDOSERIE sui social:https://www.facebook.com/mondoserie https://www.instagram.com/mondoserie.it/   https://www.youtube.com/channel/UCwXpMjWOcPbFwdit0QJNnXQ  https://www.linkedin.com/in/mondoserie/ 

Americans don't talk about state attorney generals very much. Technically it's “attorneys general”—like “sisters-in-law” instead of “sister-in-laws”—but don't get hung up on the wording. It's what AGs actually do that matters so much.A state attorney general is basically the top legal expert in their state; they're also known as The People's Lawyers because they fight for us, their constituents, against bad actors who don't have our best interests in mind. That can mean prosecuting companies that are polluting waterways or landlords who are illegally raising rent prices or banks that are selling people's private data. Sometimes state AGs band together on lawsuits, like a recent case against Purdue Pharma for aggressively pushing medications like OxyContin and contributing to the opioid crisis we're facing in this country.Unfortunately, we also have a lot of examples of the harm that a corrupt or extremist attorney general can do. (Ken Paxton, for example) But the good news is, we the people have the power to elect them. In all but seven states (AK, HI, NH, NJ, WY, TN, & ME), voters choose their AG at the ballot box. Most attorneys general are up for election in 2026 or 2028, and in one pivotal state, Virginia, voters will get to elect a new attorney general in just a couple of months.This November, Jay Jones—a lawyer and former member of the Virginia House of Delegates—will square off against the current Virginia Attorney General, Jason Miyares. Miyares is a Republican and a supporter of Donald Trump, campaigning for him and supporting his policies.If you live in Virginia, be sure you come to the polls in November prepared to vote for attorney general. And if you don't live in Virginia, chances are you'll have the chance to vote for your own AG very soon! It's not just about rejecting extremism. It's about choosing a “People's Lawyer” who actually works for the people.For a transcript of this episode, please email comms@redwine.blue. You can learn more about us at www.redwine.blue or follow us on social media! Twitter: @TheSWPpod and @RedWineBlueUSA Instagram: @RedWineBlueUSA Facebook: @RedWineBlueUSA YouTube: @RedWineBlueUSA

Americans don't talk about state attorney generals very much. Technically it's “attorneys general”—like “sisters-in-law” instead of “sister-in-laws”—but don't get hung up on the wording. It's what AGs actually do that matters so much.A state attorney general is basically the top legal expert in their state; they're also known as The People's Lawyers because they fight for us, their constituents, against bad actors who don't have our best interests in mind. That can mean prosecuting companies that are polluting waterways or landlords who are illegally raising rent prices or banks that are selling people's private data. Sometimes state AGs band together on lawsuits, like a recent case against Purdue Pharma for aggressively pushing medications like OxyContin and contributing to the opioid crisis we're facing in this country. The company settled for $7.4 billion dollars just this past January, which means billions of dollars that can now be put back into treatment and prevention programs. It's a great example of how an attorney general can have a real positive impact on the people of their state.Unfortunately, we also have a lot of examples of the harm that a corrupt or extremist attorney general can do. (Ken Paxton, for example) But the good news is, we the people have the power to elect them. In all but seven states (AK, HI, NH, NJ, WY, TN, & ME), voters choose their AG at the ballot box. Most attorneys general are up for election in 2026 or 2028, and in one pivotal state, Virginia, voters will get to elect a new attorney general in just a couple of months.This November, Jay Jones—a lawyer and former member of the Virginia House of Delegates—will square off against the current Virginia Attorney General, Jason Miyares. Miyares is a Republican and a supporter of Donald Trump, campaigning for him and supporting his policies.If you live in Virginia, be sure you come to the polls in November prepared to vote for attorney general. And if you don't live in Virginia, chances are you'll have the chance to vote for your own AG very soon! It's not just about rejecting extremism. It's about choosing a “People's Lawyer” who actually works for the people.

What’s Trending: Washington State won't settle opioid lawsuit with Purdue Pharma, community task force considered for policy oversight and it’s an awful idea, despite rampant bad bicycling, tickets for violations down, and Ocasio-Cortez makes student loan payment during House panel hearing on school debt. Jacob Sullum (Reason) on the bad move to ban flavored e-cig products  Piers Morgan trashes teaching kids in school there are ‘100 gender identities.’

===== MDJ Script/ Top Stories for September 12th Publish Date:  September 12th    Commercial: From the BG AD Group Studio, Welcome to the Marietta Daily Journal Podcast.    Today is Friday, September 12th and Happy Birthday to Jesse Owens I’m Keith Ippolito and here are the stories Cobb is talking about, presented by Times Journal Golfers tee off for a cause at 27th Alexis Grubbs Memorial Tournament Cobb OKs additional funding for South Cobb Library Expansion Cobb opts to settle with Purdue Pharma, Sacklers and other opioid manufacturers Plus, Leah McGrath from Ingles Markets on fast food All of this and more is coming up on the Marietta Daily Journal Podcast, and if you are looking for community news, we encourage you to listen and subscribe!  BREAK: Ingles Markets 10 STORY 1: Golfers tee off for a cause at 27th Alexis Grubbs Memorial Tournament This week, the 27th annual Alexis Grubbs Memorial Scholarship Golf Tournament teed off at Brookstone Country Club, bringing together over 100 golfers, sponsors, and volunteers for a day of camaraderie and purpose. Players grabbed gift bags (thanks to A 2nd Chance Bail Bonds), fueled up on Chick-fil-A biscuits, and hit the course after opening remarks from Carlos Rodriguez, the tournament chair. By 10:30 a.m., the Shotgun Start was underway. The event honors Alexis Grubbs, a Marietta High senior tragically lost in 1998, and has since awarded over $500,000 in scholarships to students pursuing legal careers. Winners? Matthew Enslein, Aaron Tomlinson, David Lyles, and Scott Lawrence. STORY 2: Cobb OKs additional funding for South Cobb Library Expansion  This week, the Cobb County Board of Commissioners greenlit $500,000 in extra funding to expand the South Cobb Regional Library by 5,000 square feet. Commissioner Monique Sheffield, who’s been pushing for this since 2021, said the project will be a game-changer for the community. The library, which opened in 2006, is one of the busiest in the county—especially for computer use. The expansion will add a new community space, a bigger teen area, and a computer lab, addressing a critical need for internet access in the area. Other board approvals? Speed signs, road projects, and grants for workforce programs. STORY 3: Cobb opts to settle with Purdue Pharma, Sacklers and other opioid manufacturers   The Cobb County Board of Commissioners has signed off on three new opioid settlements, but not without some debate. The vote was 3-1, with Commissioner Keli Gambrill opposing and Erick Allen absent. The settlements include payouts from Purdue Pharma, the Sackler family, and eight other manufacturers, all tied to their role in fueling the opioid epidemic. Cobb could see nearly $1 million from Sandoz alone, with funds earmarked for addiction treatment, prevention, and education. We have opportunities for sponsors to get great engagement on these shows. Call 770.799.6810 for more info.  We’ll be right back. Break: COBB MAKE A WISH STORY 4: 'Our city is strong': Mableton holds inaugural State of the City address With dancers, a marching band, and a crowd of hundreds, Mayor Michael Owens delivered Mableton’s first-ever State of the City address, blending optimism with a dose of realism. “The state of our city is strong,” Owens declared, but he didn’t shy away from the challenges. Roads, bridges, infrastructure—there’s work to do. Still, he painted a vision of a diverse, united, and thriving Mableton, calling it “not just another Atlanta suburb” but a cultural destination. Owens highlighted the city’s $13 million budget—no property taxes yet—and plans for affordable housing, smart growth, and a pedestrian-friendly future. STORY 5: OUT AND ABOUT: 5 things to do this weekend in Cobb County — Sept. 12 - 14 Fright Fest at Six Flags Ready to scream? Six Flags Over Georgia’s Fright Fest is back, running select nights through Nov. 2. Starting at 6 p.m., you can wander haunted mazes, dodge scare zones, catch creepy live shows, and ride coasters in the dark. Tickets? $69 for all-day access or $35 if you’re just here for the haunted mazes. Marietta Artisan Market Saturday morning plans? Head to downtown Marietta for the weekly artisan market on Mill Street, 9 a.m. to 1 p.m. Over 35 artists will be there, including this week’s spotlight: Jess Hain, who crafts stunning sterling silver jewelry and stained glass sun catchers. Coffee, Campfire, and Cryptids Friday night, grab some cocoa and dive into Marietta’s spookiest legends at Coffee, Campfire, and Cryptids in Atherton Square. Wendigos, mysterious creatures, and folklore-inspired goodies await. Starts at 6 p.m. Comedy on the Square Need a laugh? The Alley Stage’s “Comedy on the Square” show hits Friday and Saturday at 8 p.m. Tickets start at $27—grab them online or at the door. Dog Days at Smith-Gilbert Gardens Bring your pup to Smith-Gilbert Gardens this Saturday, 9 a.m. to 4 p.m., for a stroll through 18 acres of greenspace. Admission’s just $3. And now here is Leah McGrath from Ingles Markets on fast food We’ll have closing comments after this. Break: Ingles Markets 10 Signoff-   Thanks again for hanging out with us on today’s Marietta Daily Journal Podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, or the Community Podcast for Rockdale Newton and Morgan Counties. Read more about all our stories and get other great content at mdjonline.com Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. Produced by the BG Podcast Network Show Sponsors: www.ingles-markets.com Cobb Make a Wish #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversations See omnystudio.com/listener for privacy information.

No Country for Old People, a documentary from filmmaker Susie Singer Carter and former federal prosecutor and US Attorney Rick Mountcastle, investigates widespread neglect and systemic failures in nursing facilities. Singer Carter tells a personal story about her mother, who lived with Alzheimer's disease and received inadequate care in a five-star facility. Mountcastle, known for prosecuting Purdue Pharma for its role in the opioid crisis, connects his legal experience exposing corporate misconduct to troubling practices he uncovered in the long-term care industry. Together, they highlight how residents with dementia and other disabilities are often silenced, overlooked, or neglected by a system that profits from their vulnerability.In this Live Talk with Being Patient's founder Deborah Kan, Carter and Mountcastle share the stories behind the film, including Singer Carter's firsthand account of her mother's decline in a care facility, and Mountcastle's insights into how legal and corporate structures perpetuate exploitation. As advocates of the ROAR(Respect, Oversight, Advocacy, and Reform for Long-Term Care) movement, they said they intend their film to give voice to the voiceless and push for accountability. 

In this powerful conclusion to our "War on Drug" series, we confront the opioid epidemic that has claimed hundreds of thousands of lives and reshaped the landscape of addiction in America. We trace the origins of the crisis back to Purdue Pharma and the Sackler family, whose aggressive marketing of OxyContin in the 1990s and early 2000s helped normalize the widespread prescribing of highly addictive painkillers.   Listeners will learn how deceptive pharmaceutical campaigns, coupled with systemic failures in regulation and oversight, created the conditions for one of the deadliest addiction waves in U.S. history. We break down:   - The rise of OxyContin and Purdue Pharma's marketing strategies   - The Sackler family's influence and pursuit of profit over public health   - How the opioid epidemic escalated into a nationwide crisis   - The human cost of addiction, from individuals to entire communities   - Where do we go from here in addressing accountability and recovery   This episode is not just about exposing the failures that fueled the epidemic,  it's about understanding the lessons we must carry forward to prevent history from repeating itself.      

Steven May is a federal whistleblower who took on one of the biggest pharmaceutical companies in the world: Purdue Pharma. His case, which once reached the Supreme Court, exposed what he believes was a calculated fraud that led to the approval of OxyContin and helped create the opioid crisis. In this powerful interview, May shares the eye-opening details he uncovered during discovery. He reveals how his legal battle, though ultimately dismissed on a technicality, would have argued that if Purdue had not made false claims about the drug's efficacy, it never would have been approved. This is a story of a David-versus-Goliath struggle, where one man's pursuit of justice uncovered a systemic failure with devastating consequences. May's experience resonates with other high-profile whistleblower cases, such as that of **Brooke Jackson** against Pfizer's mRNA vaccines. He's previously been interviewed by major news outlets like *The New Yorker* and France 24, and now, he's ready to tell his complete story. Tune in to hear how Steven May's fight against corporate power sheds light on the origins of the opioid crisis and the critical role whistleblowers play in holding powerful institutions accountable. HELP SUPPORT OUR FIGHT AGAINST ADDICTION. DONATE HERE: https://www.patreon.com/theaddictionpodcast   PART OF THE GOOD NEWS PODCAST NETWORK. AUDIO VERSIONS OF ALL OUR EPISODES: https://theaddictionpodcast.com CONTACT US: The Addiction Podcast - Point of No Return theaddictionpodcast@yahoo.com Intro and Outro music by: Decisions by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Source: http://incompetech.com/music/royalty-free/index.html?isrc=USUAN1100756 Artist: http://incompetech.com/

Ed Bisch is an activist who founded Relatives Against Purdue Pharma (RAPP) after his son, Eddie, died from an OxyContin overdose in 2001. After Eddie's death, Ed started a website to warn others about the dangers of OxyContin and began connecting with other parents who had lost children to the drug. This led to the formation of RAPP, a group that has been actively protesting and seeking to hold Purdue Pharma and the Sackler family accountable for their role in the opioid crisis. Key details about Ed Bisch and RAPP: Formation: Ed Bisch founded RAPP around 2003 with three other mothers who also lost children to opioids. Anyone who has stood up to Purdue Pharma or spoken out against them is considered a member. Activism: RAPP is known for holding protests and attending hearings, often with photos of their deceased children, to keep pressure on the company and its owners. Ed has also been a claimant in a class-action lawsuit against Purdue Pharma and the Sackler family. Goal: The primary goal of RAPP is for Purdue Pharma and the Sackler family executives to receive jail time for their involvement in the opioid crisis, arguing that financial penalties are not enough of a deterrent. Media Attention: Ed Bisch's activism has been featured in various media, including the MTV series "True Life," the MSNBC special "The Forgotten Epidemic," and articles by authors like Beth Macy ("Dopesick" and "Raising Lazarus"). He has been a consistent voice calling for the Department of Justice to prosecute the Sacklers. Settlement Views: Ed Bisch has been vocal in his criticism of the various settlements reached with the Sackler family, calling them "a bankruptcy scam" and a "sad joke" because the payouts to victims are very small and the Sacklers' fortune remains largely untouched. He also points out that the settlements often include immunity from future civil lawsuits. HELP SUPPORT OUR FIGHT AGAINST ADDICTION. DONATE HERE: https://www.patreon.com/theaddictionpodcast   PART OF THE GOOD NEWS PODCAST NETWORK. AUDIO VERSIONS OF ALL OUR EPISODES: https://theaddictionpodcast.com CONTACT US: The Addiction Podcast - Point of No Return theaddictionpodcast@yahoo.com Intro and Outro music by: Decisions by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Source: http://incompetech.com/music/royalty-free/index.html?isrc=USUAN1100756 Artist: http://incompetech.com/

Pulitzer Prize-winning novelist Barbara Kingsolver joins co-hosts Whitney Terrell and V.V. Ganeshananthan to discuss her support of Higher Ground, a long-term residence for women recovering from addiction. Kingsolver talks about Lee County, Virginia, which is both Higher Ground's location and the setting for her wildly successful novel Demon Copperhead, which transforms Charles Dickens' David Copperfield into a story of the opioid epidemic in Appalachia. Kingsolver explains how she came to use profits from the novel to found Higher Ground, as well as the local partnerships and conversations that made the project possible. She also reflects on Purdue Pharma's exploitation of Appalachia; her views on ethical philanthropy; her worries about what the Big, Beautiful Bill will do to rural America; and her opinions on Vice President J.D. Vance's authenticity. She considers how she developed the voices of her novel's characters, and reads from Demon Copperhead. To hear the full episode, subscribe through iTunes, Google Play, Stitcher, Spotify, or your favorite podcast app (include the forward slashes when searching). You can also listen by streaming from the player below. Check out video versions of our interviews on the Fiction/Non/Fiction Instagram account, the Fiction/Non/Fiction YouTube Channel, and our show website: https://www.fnfpodcast.net/ This podcast is produced by V.V. Ganeshananthan, Whitney Terrell, Hunter Murray, Janet Reed, and Moss Terrell. Barbara Kingsolver Demon Copperhead Higher Ground Women's Recovery Residence Unsheltered Flight Behavior The Lacuna Animal, Vegetable, Miracle: A Year of Food Life The Poisonwood Bible Pigs in Heaven Others: "‘I've dealt with anti-hillbilly bigotry all my life': Barbara Kingsolver on JD Vance, the real Appalachia and why Demon Copperhead was such a hit" |The Guardian   Nickel and Dimed: On (Not) Getting By in America by Barbara Ehrenreich Hillbilly Elegy by J.D. Vance Learn more about your ad choices. Visit megaphone.fm/adchoices

The Boy Scouts of America bankruptcy case, involving tens of thousands of survivors of childhood sexual abuse, is among the largest and most contentious mass tort proceedings in U.S. history. Today on Cut to the Chase, Attorney Jason Joy breaks down the latest ruling from the Third Circuit Court, which leaves many survivors of childhood sexual abuse with drastically underfunded compensation. He explains how this case differs from the Purdue Pharma/Sackler opioid litigation and why legal strategy matters. The episode reveals how survivors may receive only pennies on the dollar, while insurance companies and institutions that haven't filed for bankruptcy avoid further accountability. Then, survivor and advocate Curtis Garrison addresses powerful new laws in Texas and Missouri that ban the use of NDAs to silence survivors of child sexual abuse. These legal changes are helping victims speak out, heal, and protect others from harm. What to expect in this episode: Circuit Conflict: How the Third Circuit's Boy Scouts bankruptcy ruling conflicts with Supreme Court precedent in Purdue Pharma “Pennies on the Dollar” Justice: Why thousands of survivors are receiving as little as 1.5% of their claims from a $30 billion pool Who Benefits? The controversial role of plaintiff firms and insurers in shaping the underfunded settlement Justice Delayed: How years of procedural delays and legal stays have eroded survivor compensation and trust Legislative Breakthroughs: How Texas and Missouri are leading the charge by banning NDAs that silence child abuse victims Trey's Law: The story behind one family's fight to protect future survivors and pass meaningful reform What's Next in Court: The path forward for potential Supreme Court review and future mass tort bankruptcy cases Lawyer Action Plan: How attorneys can support clients, push for legislative reform, and avoid similar outcomes in future settlements Key Actionable Takeaways: Audit your use of NDAs in abuse cases to ensure you're not silencing survivors, especially in states where such clauses are now banned. Stay current on court rulings like Purdue Pharma and Boy Scouts to understand how legal precedents may impact third-party releases and mass tort strategies. Push for full transparency in settlement agreements so clients clearly understand how much is funded, how much they'll actually receive, and the risks of appeals. Support survivor-focused legislation by joining advocacy efforts to eliminate statutes of limitations and expand legal protections nationwide.   Stay tuned for more updates, and don't miss our next deep dive on Cut to the Chase: Podcast with Gregg Goldfarb!   Subscribe, rate, review, and share this episode of the Cut to the Chase: Podcast!   Resources: Speak Out to Stop Child Sexual Abuse: https://soscsa.org Jason Joy & Associates: https://www.jasonjoylaw.com Connect with Jason on LinkedIn: https://www.linkedin.com/in/jason-joy-595a3416 Listen to our first Boy Scouts breakdown (Feb 2024) with Jason Joy: https://bit.ly/4m62Y3s  Listen to our last Boy Scouts update (Dec 2024) with Jason and Curtis: https://bit.ly/45einZU   This episode was produced and brought to you by Reignite Media.

When award-winning filmmaker Susie Singer Carter placed her mother, who was living with dementia, in a five-star nursing home in Los Angeles, she never expected to be dealing with substandard care, inadequate staffing, and chemical restraints. Horrified by what was happening, Susie connected with former federal prosecutor Rick Mountcastle, whose prosecution of Purdue Pharma was featured in the miniseries, Dopesick. Susie and Rick have collaborated on a new documentary, No Country for Old People, to raise awareness about failures in our long-term care system and spur action to promote quality and accountability. On the eve of the release of the documentary, join a conversation with Susie and Rick about what they've learned in this process and what you can do to help change the system. Guests: Guest: Susie Singer Carter, Writer and Director, and Rick Mountcastle, Former Federal Prosecutor

All Home Care Matters and our host, Lance A. Slatton were honored to welcome back the team behind the film "No Country for Old People"   About "No Country for Old People":   A filmmaker chronicles her mother's last 6 months in a 5-star nursing home exposing what is a national systemic, deadly, profit-over-people business model. No Country For Old People; a Nursing Home Exposé is a scorching documentary posed to set the long-term care industry, policy makers, and the country ablaze. Shining a much-needed light on what is truly a national human emergency.   No Country for Old People; a Nursing Home Exposé is a 3-part documentary that exposes the dark realities of neglect and abuse in nursing homes and throughout U.S. long-term care industry.   The film answers four questions: What happens. 2. How does it happen? 3. Why does it happen? 4. And how do we fix it?   The film highlights a systemic crisis - the result of corporate greed - that has been taking a devastating human toll within the walls of our nation's long-term care facilities for decades.   The film weaves personal loss with journalistic rigor, exposing a pattern of abuse that is enabled by profit-first models that include chronic understaffing, undertraining, and financial exploitation.   PERSONAL STORIES AND EMOTIONAL IMPACT:   The filmmaker's own experience with her mother along with other emotional testimonies emphasize the human cost of systemic failure and illustrate the severe consequences of poor nursing home care.   The film is both deeply personal and widely resonant — amplifying voices too often silenced and inviting viewers to confront uncomfortable truths about aging, policy, and accountability in America.   About Susie Singer Carter:   Susie Singer Carter is a multi-award-winning, Oscar qualified filmmaker, writer, director, producer, actor, podcast producer, host, and Caregiver Advocate. She is best known for writing, directing, and producing the 2018 Oscar qualified short film, My Mom and The Girl starring Valerie Harper in her final performance, writing and producing “Bratz the Movie” for Lionsgate, and co-producing “Soul Surfer” for Sony.   Susie also produces and hosts the podcast Love Conquers Alz – awarded BEST PODCAST 2020 by New Media Film Festival and is #4 on Feedspots' 2022 25 Best Alzheimer's Podcasts list. Susie is also the co-creator, co-writer, co-star, and director of the outrageous horror/comedy narrative podcast I Love Lucifer, nominated Best Audio Fiction 2023 by Indie Series Awards.   Susie wrote the screenplay, “RUN”, based on the book “Plain Jane” and is attached to direct in spring 2024. She is currently writing, producing, and directing a docuseries, No Country For Old People, which centers on the Nursing Home Neglect and the systemic healthcare crisis responsible for it. She is also a host of the Writers Guild of America West's 3rd & Fairfax Podcast.   About Rick Mountcastle:   Mr. Mountcastle is the former United States Attorney for the Western District of Virginia (2017-2018) and is a retired award-winning federal and state prosecutor. He led the prosecution of Purdue Pharma for fraudulently marketing OxyContin, as portrayed in the Emmy-nominated limited miniseries "Dopesick" (streaming on Hulu).   He also led the criminal and civil prosecution of Abbott Laboratories for fraudulently marketing the anti-epileptic, Depakote, for use as a chemical restraint for dementia patients in nursing homes, resulting in Abbott's guilty plea to a felony and payment of $1.5 billion, at the time the largest penalty against a pharmaceutical company for misconduct related to a single drug.   Mr. Mountcastle spent his career prosecuting healthcare companies and executives who exploited vulnerable patients for profit, and brings his passion to change a system that allows such exploitation to this project.   About Don Priess:   For over two decades, Don Priess has shunned sleep in order to become a highly sought-after, award winning writer, producer, director and editor. He co-founded Modern Media, now one of the top marketing and infomercial production companies in the world.   After six years and hundreds of TV and radio commercials, Don decided to spread his wings and since his credits include projects for CBS/Dic Entertainment, Nickelodeon, Buena Vista, American Movie Classics, Lifetime, Hanna-Barbera, Playboy Entertainment and more.   While continuing to work on a wide variety of entertainment projects, Don teamed with the highly energetic and talented Susie Singer Carter as part of Go Girl Media. Together they were the writers and Co-Executive Producers of two series for CBS, “CAKE” and “DANCE REVOLUTION”, SURVIVING HAWKING, and “SILVER LININGS” for Fox Television Studios.

Alzheimer's and elder care demand our attention not just because millions endure them, but because the systems that are supposed to protect our most vulnerable are fundamentally broken. In light of the upcoming release of our documentary, No Country For Old People; a Nursing Home Exposé, August 1st on Amazon, my producing partner and today's guest host, Rick Mountcastle (whose work prosecuting Purdue Pharma was dramatized in Hulu's "Dopesick") and I are turning our focus on elder abuse.  In this powerful episode, we're joined by Richard Routman, whose 14-year career at the Department of Health and Human Services gave him a front-row seat to nursing home neglect cases, pulls back the curtain on why elder abuse persists despite seemingly robust regulations. The reality is sobering: residents fear retaliation if they report mistreatment, staff worry about losing jobs if they speak up, and facility administrators actively obstruct investigations by altering records or instructing employees to "forget" incidents when questioned by surveyors. Meanwhile, the regulatory landscape remains fragmented between federal agencies, state surveyors, Adult Protective Services, and law enforcement—creating dangerous gaps where abuse reports disappear. Most troubling is how money influences the entire system. The nursing home industry spends hundreds of millions annually on political contributions and lobbying, effectively buying themselves protection from meaningful reform. As Richard notes, ordinary citizens advocating for better care are "fighting with sticks" while the industry fights "with guns." Yet this conversation offers hope through specific action steps. Every county has a Commission on Aging that citizens can join to question officials and advocate for improved oversight. Families should learn their rights regarding documenting care—in many cases, they can legally record conditions despite what staff might claim. Most importantly, Richard reminds us that cultural change starts with rejecting the ageism that treats elder abuse as somehow less urgent than child abuse. Don't miss our documentary "No Country for Old People" launching on Amazon August 1st. Until then, remember that knowledge, community action, and love remain our most powerful tools against a system that too often fails those who built our world. Support the show Be a ROAR-ior!! JOIN THE R.O.A.R. MOVEMENT for quality long term care! Visit the No Country For Old People Website for more information. YOU CAN ALSO SUPPORT THE ABSOLUTELY CRUCIAL PROMOTION OF OUR DOCUMENTARY "NO COUNTRY FOR OLD PEOPLE" BY MAKING A TAX DEDUCTIBLE DONATION THROUGH THE NATIONAL CONSUMER VOICE HERE Follow us on Twitter, FB, IG, & TiK Tok 

Alzheimer's and elder care demand our attention not just because millions endure them, but because the systems that are supposed to protect our most vulnerable are fundamentally broken. In light of the upcoming release of our documentary, No Country For Old People; a Nursing Home Exposé, August 1st on Amazon, my producing partner and today's guest host, Rick Mountcastle (whose work prosecuting Purdue Pharma was dramatized in Hulu's "Dopesick") and I are turning our focus on elder abuse.  In this powerful episode, we're joined by Richard Routman, whose 14-year career at the Department of Health and Human Services gave him a front-row seat to nursing home neglect cases, pulls back the curtain on why elder abuse persists despite seemingly robust regulations. The reality is sobering: residents fear retaliation if they report mistreatment, staff worry about losing jobs if they speak up, and facility administrators actively obstruct investigations by altering records or instructing employees to "forget" incidents when questioned by surveyors. Meanwhile, the regulatory landscape remains fragmented between federal agencies, state surveyors, Adult Protective Services, and law enforcement—creating dangerous gaps where abuse reports disappear.Most troubling is how money influences the entire system. The nursing home industry spends hundreds of millions annually on political contributions and lobbying, effectively buying themselves protection from meaningful reform. As Richard notes, ordinary citizens advocating for better care are "fighting with sticks" while the industry fights "with guns."Yet this conversation offers hope through specific action steps. Every county has a Commission on Aging that citizens can join to question officials and advocate for improved oversight. Families should learn their rights regarding documenting care—in many cases, they can legally record conditions despite what staff might claim. Most importantly, Richard reminds us that cultural change starts with rejecting the ageism that treats elder abuse as somehow less urgent than child abuse.Don't miss our documentary "No Country for Old People" launching on Amazon August 1st. Until then, remember that knowledge, community action, and love remain our most powerful tools against a system that too often fails those who built our world.Support the showBe a ROAR-ior!! JOIN THE R.O.A.R. MOVEMENT for quality long term care! Visit the No Country For Old People Website for more information.YOU CAN ALSO SUPPORT THE ABSOLUTELY CRUCIAL PROMOTION OF OUR DOCUMENTARY "NO COUNTRY FOR OLD PEOPLE" BY MAKING A TAX DEDUCTIBLE DONATION THROUGH THE NATIONAL CONSUMER VOICE HERE Follow us on Twitter, FB, IG, & TiK Tok

In this episode of the Faces of the Future Podcast the guys are back from having last week off. They recapped everything they had missed. They discuss Shai potentially being the new face of the NBA, the U.S. sending strikes to Iran, they react to Purdue Pharma settling for $7.4 Billion for playing their part in the opioid crisis, for more star Henry Ruggs being released from jail, plus more.Support the show

Next year's Pennsylvania gubernatorial race is already on the political horizon. So far, the Republican field is shaping up with three prominent figures expressing interest. EMTs could soon be authorized to give caregivers medication that would reverse opioid overdoses, as a bill is quickly moving through the state Capitol. Pennsylvania could receive as much as 200 million dollars as part of a massive settlement with drug maker Purdue Pharma. That's according to PA Attorney General Dave Sunday. The payout is part of a $7.4 billion deal, stemming from the opioid crisis, in which prosecutors and addiction experts say Purdue and its owners the Sackler family played a major role. A portion of land in Somerset County is now protected through a recent acquisition by The Nature Conservancy. The land is part of a critical ecosystem, and it's being added to State Game Lands 82. Police say an 18-year old stabbed his father to death with a machete-style knife during an early-morning argument Tuesday in their West York home. Raw milk sold in Lancaster County and throughout Central Pennsylvania is contaminated and should be thrown out, according to the Pennsylvania Department of Agriculture. The milk is contaminated with an infectious intestinal disease. The affected milk is Meadow View Jerseys brand raw milk purchased since April 1 with sell-by dates between April 15 and July 8. A Pennsylvania college is addressing its growing financial issues by auctioning its art collection. Albright College, located in Reading, Berks County - according to a report by our partners at Spotlight PA - is preparing to auction more than 2,000 pieces of art. Gov. Josh Shapiro was joined by Philadelphia Eagles Hall of Famer LeSean McCoy, at the official ribbon-cutting for a new 41-unit housing complex in Harrisburg, to benefit low and moderate income home buyers. And comedian and actor Shane Gillis, a Mechanicsburg native, will be hosting this year's ESPYS awards show. Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

AP correspondent Jennifer King reports on a bankruptcy judge's ruling on opioid lawsuits against Purdue Pharma.

President Trump has been briefed on both the risks and benefits of bombing Iran's Fordo nuclear facility. CBS News has learned the president believes that if talks fail, disabling the facility will be necessary because of the risk of weapons being produced in a relatively short period of time, multiple sources told CBS News. A federal bankruptcy judge will decide on Friday whether to approve a nearly $7.5 billion settlement involving OxyContin maker Purdue Pharma. Severe storms are bringing thunder, lightning and heavy rain to parts of the East Coast. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

A historic and national $7.4 billion dollar settlement has been reached with Purdue Pharma, the maker of the opioid OxyContin that spurred a major start of the opioid epidemic. A prior settlement had been struck down by the Supreme Court. NPR'S national addiction correspondent, Brian Mann, joins Lisa Desjardins with more. PBS News is supported by - https://www.pbs.org/newshour/about/funders

State lawmakers finally adjourn for the 2025 legislative session after working overtime to pass a sweeping education reform bill. Plus, Vermont agrees to the terms of a multi-state settlement with Purdue Pharma, the state health department plans to expand its partnerships with organizations that offer HIV testing, and a new historic marker will be unveiled in Weybridge to commemorate an openly same-sex couple who lived there in the 19th century. 

A historic and national $7.4 billion dollar settlement has been reached with Purdue Pharma, the maker of the opioid OxyContin that spurred a major start of the opioid epidemic. A prior settlement had been struck down by the Supreme Court. NPR'S national addiction correspondent, Brian Mann, joins Lisa Desjardins with more. PBS News is supported by - https://www.pbs.org/newshour/about/funders

The Indiana Pacers will return to Indianapolis fighting to stay alive in the NBA Finals. The Indianapolis Office of Sustainability recently released its annual report highlighting local advancements toward a more environmentally-friendly future. Attorney General Todd Rokita announced Monday that 55 attorneys general have agreed to a settlement with Purdue Pharma and its owners, the Sackler family. Nearly 1,000 Indiana union workers at Duke Energy are preparing for a potential strike. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Drew Daudelin, Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

Israel has expanded its attacks on targets inside Iran to include the country's state television studios. The suspect accused of killing a Minnesota lawmaker and her husband faces federal and state murder charges, and Purdue Pharma and members of the Sackler family have reached a multibillion dollar settlement with states. Want more comprehensive analysis of the most important news of the day, plus a little fun? Subscribe to the Up First newsletter.Today's episode of Up First was edited by Vincent Ni, Cheryl Corley, Andrea DeLeon, Janaya Williams and Alice Woelfle. It was produced by Ziad Buchh, Claire Murashima, and Christopher Thomas. Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Last night's Pacers game was rough to watch, Is the US about to go on a bombing run on Iran? Maneuvers in the Middle East, Is the US bringing the bunker buster with them? Trump smacking down Macron, It's a scam! Trump wants blue cities targeted for deportation first, IBJ calls for Hogsett's resignation. States agree to $7.4 billion settlement with Purdue Pharma in opioid litigation, Trump wants an end not a ceasefire, Get Your Happy Meal Purse, They should have done the deal. The Iranians need to topple the Ayatollah. IBJ calls for Hogsett resignation. Welcome to the party IBJ, Pharmaceutical company planning to relocate from California to Fishers, Le Peep rebrands to Maple, Nearly 1 million illegal immigrants have 'self deported' under Trump, Big Beautiful Bill riding on SALT, Rokita first state AG to threaten private colleges over DEI, echoing Trump with Harvard, Time to end the Ayatollah regime See omnystudio.com/listener for privacy information.

States agree to $7.4 billion settlement with Purdue Pharma in opioid litigation, Trump wants an end not a ceasefire, Get Your Happy Meal Purse, They should have done the deal. The Iranians need to topple the Ayatollah See omnystudio.com/listener for privacy information.

Inside INdiana Business Radio for the morning of June 17, 2025. As Bloomington's $52 million convention center expansion moves ahead, a companion hotel project faces delays tied to financing plans. Indiana is set to receive up to $100 million from the Purdue Pharma opioid settlement. Also: Autocam Medical plans a $70 million facility in Warsaw, Toyota hits 1 million hybrid vehicles in Princeton, and Elkhart unveils an $8 million streetscape project. Get the latest business news from throughout the state at InsideINdianaBusiness.com.

SUBSCRIBE TO JORDAN'S ⁠FREE NEWSLETTER⁠. Get the facts, without the spin. UNBIASED offers a clear, impartial recap of US news, including politics, elections, legal news, and more. Hosted by lawyer Jordan Berman, each episode provides a recap of current political events plus breakdowns of complex concepts—like constitutional rights, recent Supreme Court rulings, and new legislation—in an easy-to-understand way. No personal opinions, just the facts you need to stay informed on the daily news that matters. If you miss how journalism used to be, you're in the right place. In today's episode: Court Blocks Trump's Control Over National Guard; Appellate Court Reverses (2:05) ICE Memo Directs Agents to Stop Conducting Workplace Raids In These Locations (6:44) CMS Reportedly Shares Medicaid Data With DHS; Here's What You Need to Know About the Legalities (10:42) States Pull Back State Medicaid Healthcare Programs for Undocumented Immigrants (16:39) Everything We Know About the Targeted Minnesota Attacks and the Shooter (20:14) "No Kings" Protests and Army Parade (33:12) Trump Releases 2024 Financial Disclosures (40:00) Quick Hitters: Washington Post Says It Was the Target of a Cyberattack, Trump Organization Announces Trump Mobile, 50 States Agree to Billion Dollar Settlement with Purdue Pharma, West Virginia Gov. Declares State of Emergency (44:34) Critical Thinking Segment (46:36) SUBSCRIBE TO JORDAN'S FREE NEWSLETTER. Watch this episode on YouTube. Follow Jordan on Instagram and TikTok. All sources for this episode can be found here.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

How did a marketing campaign lead to one of the worst public health disasters in American history?  In this episode, I investigate the rise and fall of the Sackler family, the pharmaceutical empire they built, and the marketing tactics that got millions addicted to opioids. You'll learn: How reframing turned OxyContin from a last resort into a “safe” everyday drug. Why a vague letter (not a study) became the foundation for Purdue's 1% addiction claim. How the Sacklers used doctors, pain groups, and celebrities to exploit authority bias. Why repeating a false claim makes it more believable (feat. the mere exposure effect). How behavioural science helped sell a deadly drug—and what we can learn from it. --- Shatterproof non-profit: https://shatterproof.org/ Empire of Pain:  https://www.penguinrandomhouse.com/books/612861/empire-of-pain-by-patrick-radden-keefe/ Sign up to my newsletter: https://www.nudgepodcast.com/mailing-list Connect on LinkedIn: https://www.linkedin.com/in/phill-agnew-22213187/ Watch Nudge on YouTube: https://www.youtube.com/@nudgepodcast/ --- Sources: ABC News. (2025). Purdue Pharma, Sackler family to pay $7.4 billion opioid settlement [Video]. YouTube. https://www.youtube.com/watch?v=1n2uuX1NaQo LastWeekTonight. (2016). Opioids: Last Week Tonight with John Oliver (HBO) [Video]. YouTube. https://www.youtube.com/watch?v=5pdPrQFjo2o CBS News. (2019). OxyContin maker facing over 2,000 opioid death-related lawsuits [Video]. YouTube. https://www.youtube.com/watch?v=mwGGlEFKrSs ABC News. (2019). Local governments file lawsuit against the family behind OxyContin [Video]. YouTube. https://www.youtube.com/watch?v=AlSDhuhLedg CBS News. (2022). Trump Organization's accounting firm cuts ties over financial statements [Video]. YouTube. https://www.youtube.com/watch?v=csAS4WLvMao BBC News. (2013). Serpentine Sackler Gallery Opening [Video]. YouTube. https://www.youtube.com/watch?v=YThcpSZIN0c CBS New York. (2021). Metropolitan Museum Of Art Will Remove Sackler Name From Galleries [Video]. YouTube. https://www.youtube.com/watch?v=p_u29BL2CQE CBC News. (2019). Dozens Storm The Guggenheim Museum In Protest Of Donor [Video]. YouTube. https://www.youtube.com/watch?v=ci_yOI3Wyto CBS News. (2019). Protestors stage a “Die In” at the Guggenheim Museum in New York [Video]. YouTube. https://www.youtube.com/watch?v=zYVvIwbxX2I CNBC Television. (2020). Would have done ‘nothing' differently in opioid crisis: Kathe Sackler says [Video]. YouTube. https://www.youtube.com/watch?v=dRl-Zjyf2UE STAT. (2017). 1998 Purdue Pharma marketing video [Video]. YouTube. https://www.youtube.com/watch?v=LaxlJXpwkzs GoLocal LIVE. (2019). Purdue Pharmaceutical Commercial 1998-Oxycontin [Video]. YouTube. https://www.youtube.com/watch?v=FCOl1exq3IM CBS News. (2017). Behind Purdue Pharma's marketing of OxyContin [Video]. YouTube. https://www.youtube.com/watch?v=V-jxKPpMvmA LastWeekTonight. (2019). Opioids III: The Sacklers: Last Week Tonight with John Oliver (HBO) [Video]. YouTube. https://www.youtube.com/watch?v=uaCaIhfETsM LastWeekTonight. (2021). McKinsey: Last Week Tonight with John Oliver (HBO) [Video]. YouTube. https://www.youtube.com/watch?v=AiOUojVd6xQ CBS News. (2018). Whistleblower: Purdue Pharma continued deceptive sales practices after guilty plea [Video]. YouTube. https://www.youtube.com/watch?v=o5qQf3Po31M Washington Post. (2019). Inside the opioid industry's marketing machine [Video]. YouTube. https://www.youtube.com/watch?v=gIlpd40CpT0 CBC News. (2018). How One Man Made The Opioid Crisis Possible [Video]. YouTube. https://www.youtube.com/watch?v=X2AUIBB34nI CBC News. (2019). Nan Goldin ‘Blizzard of Prescriptions' Sackler Pain Guggenheim Protest & Die-In 2/9/19 [Video]. YouTube. https://www.youtube.com/watch?v=q2A4Tb8cOxE Keefe, P. R. (2021). Empire of Pain: The Secret History of the Sackler Dynasty. Doubleday.  Cialdini, R. B. (2006). Influence: The Psychology of Persuasion (Revised ed.). Harper Business.

An interview with investigative journalist Gardiner Harris regarding his newly released exposé No More Tears that unpacks Johnson & Johnson's white collar criminality, murderous corporate malfeasance, and myriad coverup conspiracies that have left millions dead.Support the show by subscribing to the PPM Patreon and gain access to a bonus, solo ep that explores Gardiner's father's fascinating career as a bureau chief at Time Inc. and protege of spooky, anticommunist publisher Henry Luce (a mini-primer on Luce's myriad ties to intelligence, Cuban paramilitaries, Gladio via his wife Clare Boothe Luce, and the JFK assassination):patreon.com/ParaPowerMapping***One day in 2004, Gardiner Harris, a pharmaceutical reporter for The New York Times, was early for a flight and sat down at an airport bar. He struck up a conversation with the woman on the barstool next to him, who happened to be a drug sales rep for Johnson & Johnson. Her horrific story about unethical sales practices and the devastating impact they'd had on her family fundamentally changed the nature of how Harris would cover the company—and the entire pharmaceutical industry. His subsequent investigations and ongoing research since that very first conversation led to this book—a blistering exposé of a trusted American institution and the largest healthcare conglomerate in the world.Harris takes us light-years away from the company's image as the child-friendly “baby company” as he uncovers reams of evidence showing decades of deceitful and dangerous corporate practices that have threatened the lives of millions. He covers multiple disasters: lies and cover-ups regarding the link of Johnson's Baby Powder to cancer, the surprising dangers of Tylenol, a criminal campaign to sell antipsychotics that have cost countless lives, a popular drug used to support cancer patients that actually increases the risk that cancer tumors will grow, and deceptive marketing that accelerated opioid addictions through their product Duragesic (fentanyl) that rival even those of the Sacklers and Purdue Pharma.Filled with shocking and infuriating but utterly necessary revelations, No More Tears is a landmark work of investigative journalism that lays bare the deeply rooted corruption behind the image of babies bathing with a smile.***Songs:| The Chemical Brothers - "The Pills Won't Help You Now" || Spiritualized - "Medication" |

The chief of the watchdog agency that protects federal workers and whistleblowers, Hampton Dellinger, was one of the first to be fired by President Trump. So were eighteen inspectors general and the chief of the board that protects federal workers. What is happening to independent watchdogs and why are they being dismantled? Correspondent Scott Pelley sits down with Dellinger and others to find out. Five years after it declared bankruptcy, Purdue Pharma and its wealthy owners, members of the Sackler family, have agreed to pay up to $7.4 billion in a proposed settlement that would deliver funds to victims of the opioid crisis. Correspondent Cecilia Vega investigates how this deal—potentially one of the largest opioid settlements ever—will affect the individuals and families who say Purdue's opioids harmed them. With the NCAA basketball tournament, famously known as “March Madness,” tipping off this month, the University of Connecticut men's team is aiming for a historic three-peat. Correspondent Jon Wertheim provides an inside look at coach Dan Hurley's preparations, his strategies for managing a changing roster, and his pre-season rituals. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

From hoodies to hip-hop, from cultural influence to corporate boardrooms—your identity is your brand's greatest asset. In this Masterclass episode, Evante Daniels returns to unpack the power of authenticity in branding and how embracing your unique identity can translate into profitability. We explore the psychology behind brand confidence, the impact of personal style in professional spaces, and why cultural IP is one of the most undervalued assets in business.But here's the truth—if you don't tie your branding and positioning to ROI, the market won't either. Evante breaks down why companies cut diversity initiatives, why cultural branding often gets overlooked, and how Black entrepreneurs can strategically position themselves to not just be seen, but to drive revenue and business growth. It's not just about showing up—it's about making sure your presence is tied to measurable impact, market share, and long-term brand equity.We also break down real-world examples of cultural branding done right—from hip-hop moguls to streetwear legends—and how businesses can leverage their narratives to elevate influence, establish credibility, and turn cultural capital into actual capital.Whether you're a creator, executive, or entrepreneur, this conversation will challenge you to rethink your brand positioning, embrace your full identity, and ensure your brand isn't just culturally relevant—but financially powerful.Tap in for Part 3 of this powerful Masterclass with Evante Daniels! Listen to Part 1 of our conversation here.Listen to Part 2 of our conversation here.Beyond The Episode Gems:Follow Evante Daniels On LinkedIn For Creative & Brand Insights, Strategy, Content, & MemesInterested In Working With Evante and Seeqer? Visit Seeqer Website For Services, Case Studies, & Getting StartedBuy Evante's Book "Power, Beats, & Rhymes: Reclaiming Our Cultural Voice"Subscribe To My New Weekly LinkedIn Newsletter: Strategize. Market. Grow.Buy My Book, Strategize Up: The Blueprint To Scale Your Business: StrategizeUpBook.comDiscover All Podcasts On The HubSpot Podcast NetworkTry GetResponse For FREE On Me To Monetize Your Content: GetResopnse Content Monetization Plan Support The Podcast & Connect With Troy: Rate & Review iDigress: iDigress.fm/ReviewsFollow Troy's LinkedIn @FindTroyNeed Growth Strategy, A Keynote Speaker, Or Want To Sponsor The Podcast? Go To FindTroy.comFollow Troy's Instagram @FindTroySubscribe to Troy's YouTube Channel

Purdue Pharma's owners in the Sackler family have agreed to a new $6.5 billion settlement to lawsuits over their role in the U.S. opioid crisis. This comes after a previous deal was rejected by the Supreme Court last year. We’ll break down the details of the settlement and what could come next. And, the U.S. housing market is the slowest it’s been in 30 years, but prices aren’t coming down. What gives? Plus, we’ll play a round of Half Full/Half Empty! Here’s everything we talked about today: “Existing-Home Sales in 2024 Were Slowest in Decades Amid High Mortgage Rates” from The New York Times “United States Housing Market & Prices” from Redfin “Purdue Pharma's Sacklers Agree to New $6.5 Billion Deal for Opioid Lawsuits” from The Wall Street “Supreme Court Jeopardizes Opioid Deal, Rejecting Protections for Sacklers” from The New York Times “Is there a market for luxury EVs? GM thinks so.” from Marketplace “This 24-hour diner helps New Yorkers make it through the night” from Marketplace “The American workweek is shrinking” from Marketplace “‘Lost’ Tina Turner track to be released 2 years after queen of rock ‘n’ roll’s death” from USA Today “UK's 20mph speed limits ‘are cutting car insurance costs'” from The Guardian We love to hear from you. Email us at makemesmart@marketplace.org or leave us a voicemail at 508-U-B-SMART.

Purdue Pharma's owners in the Sackler family have agreed to a new $6.5 billion settlement to lawsuits over their role in the U.S. opioid crisis. This comes after a previous deal was rejected by the Supreme Court last year. We’ll break down the details of the settlement and what could come next. And, the U.S. housing market is the slowest it’s been in 30 years, but prices aren’t coming down. What gives? Plus, we’ll play a round of Half Full/Half Empty! Here’s everything we talked about today: “Existing-Home Sales in 2024 Were Slowest in Decades Amid High Mortgage Rates” from The New York Times “United States Housing Market & Prices” from Redfin “Purdue Pharma's Sacklers Agree to New $6.5 Billion Deal for Opioid Lawsuits” from The Wall Street “Supreme Court Jeopardizes Opioid Deal, Rejecting Protections for Sacklers” from The New York Times “Is there a market for luxury EVs? GM thinks so.” from Marketplace “This 24-hour diner helps New Yorkers make it through the night” from Marketplace “The American workweek is shrinking” from Marketplace “‘Lost’ Tina Turner track to be released 2 years after queen of rock ‘n’ roll’s death” from USA Today “UK's 20mph speed limits ‘are cutting car insurance costs'” from The Guardian We love to hear from you. Email us at makemesmart@marketplace.org or leave us a voicemail at 508-U-B-SMART.

Today's Headlines: Trump's first week back has been eventful. Pete Hegseth's Defense Secretary nomination heads to a final vote, while John Ratcliffe is confirmed as CIA director. A new GOP-led January 6th committee was launched and Speaker Johnson has discouraged subpoenaing Cassidy Hutchinson amid fears of exposing lawmakers' explicit texts. Trump's order to limit birthright citizenship faced its first legal challenge, with a federal judge issuing a restraining order, calling it "blatantly unconstitutional." Meanwhile, Trump considers cutting FEMA as wildfires rage in Los Angeles, burning over 10,000 acres and prompting mass evacuations. In Nashville, a school shooting left two dead and two injured, despite AI weapon detection software failing. His manifesto cited Candace Owens and Adolf Hitler as inspirations. Lastly, the Sacklers agreed to a $7.4B settlement over Purdue Pharma's opioid crisis role. Resources/Articles mentioned in this episode: AP News: Senate advances Pete Hegseth as Trump's defense secretary, despite allegations NBC News: Senate confirms John Ratcliffe to be Trump's CIA director Axios: House GOP launches new panel to investigate Jan. 6  WA Post: Johnson aide discouraged Hutchinson subpoena over concerns about lawmakers' ‘sexual texts'  NBC News: Federal district court judge temporarily blocks Trump's birthright citizenship order CBS News: Hughes Fire in LA County burns 10,000 acres, containment rises as some evacuations remain The Guardian: ‘Setting us up for catastrophe': alarm at Trump attack on federal disaster agency  Tennessean: Antioch school shooting updates: Nashville mayor emphasizes community 'togetherness,' fundraiser NBC News: Purdue Pharma, Sackler family to pay $7.4 billion in settlement to OxyContin lawsuits Morning Announcements is produced by Sami Sage alongside Bridget Schwartz and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners to settle lawsuits alleging that their drug OxyContin helped fuel the opioid crisis — but it still has to be approved by a U.S. Bankruptcy Court. We’ll learn more about all the deal entails. Then, we’ll discuss mortgage rates, job creation and immigration. And after, as Congress struggles with tech legislation, states aim to regulate online privacy